Abstract
This study is carried out to determine the prevalence of metabolic syndrome (MS) in 148 women between 36 to 65 years using the International Diabetes Federation criteria in the North-Eastern part of India. The prevalence of MS and all its individual components were found to be significantly higher among postmenopausal as compared to premenopausal and perimenopausal women. Various components of MS except waist circumference shows a significant increase and homeostasis model assessment index for insulin resistance also showed significant differences between the three groups. All the MS diagnostic markers (except serum high density lipoprotein) showed a strong positive correlation with MS score among the groups. Further MS score correlated with indicators of insulin resistance evaluated. This study concluded that MS is highly prevalent among North-East Indian postmenopausal women seeking primary health care and its determinant factors related to age and sedentary habits. Thus recognizing and treating MS early with proper intervention can minimize complication.
Similar content being viewed by others
References
Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995;123:673–5.
Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol. 1997;11:341–55.
Satter N, Gaw A, Scherbakava O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic Syndrome with and without CRP as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study. Circulation. 2003;108:414–9.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute: definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.
Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094–101.
Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004;20:482–91.
Wasir JS, Misra A, Vikram NK, Pandey RM, Luthra K. C-reactive protein, obesity, and insulin resistance in postmenopausal women in urban slums of North India. Diabetes Metab Syndr Clin Res Rev. 2007;1:83–9.
Wasir JS, Misra A. The metabolic syndrome in Asian Indians: the impact of nutritional and socio-economic transition in India. Metab Syndr Relat Disord. 2004;2:14–23.
Chatterjee SS, Banerjee A, Dutta S, Guha S, Mazumder B, Sanyal R, et al. Risk factors for myocardial infarction in Indian women. Indian Heart J. 1987;39(6):57–69.
Al-Azzawi F. The menopause and its treatment in perspective. Postgrad Med J. 2001;77:292–304.
Misra A. Revision of limits of body mass index to define overweight and obesity are needed for the Asian ethnic groups. Int J Obes Relat Metab Disord. 2003;27:1294–6.
Rifai N, Bachorik PS, Albers JJ. Lipids, lipoprotein and apolipoprotein. In: Burtis CA, Ashwood R, editors. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia: W.B. Saunders Company; 1999. p. 806–61.
Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–482.
Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, et al. Direct measurement of High-Density Lipoprotein Cholesterol in serum with polyethylene glycol-modified enzymes and sulphated alpha-cyclodextrin. Clin Chem. 1995;41:717–23.
Trinder P. Determination of glucose in serum, plasma and CSF. GOD/POD method. Ann Clin Biochem. 1996;6:24–27.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Volund A. Conversion of insulin units to SI units. Am J Clin Nutr. 1993;58:714–5.
Lundy LE, Lee SG, Levy W, Woodruff JD, Wu CH, Abdalla M. The ovulatory cycle: a histologic, thermal, steroid and gonadotropin correlation. Obstet Gynecol. 1974;44(1):14–25.
Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2.
Pandey S, Srinivas M, Agashe S, Joshi J, Galvankar P, Prakasam CP, Vaidya R. Menopause and metabolic syndrome: a study of 498 urban women from western India. J Mid-life Health. 2010;1:63–9.
Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S. The WHO and NCEP/ATPIII definitions of the metabolic syndrome in postmenopausal women: Are they so different? Metab Syndr Relat Disord. 2006;4:17–27.
Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women’s Health Across the Nation. Arch Intern Med. 2008;168(14):1568–75.
Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N, Sarrafzadegan N. Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study. Diabetol Metab Syndr. 2010;2:59.
Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93:S9–30.
Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA Project. J Clin Epidemiol. 1999;52:1213–24.
Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes. 2006;30:106–11.
Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:2329–35.
Vikram NK, Pandey RM, Misra A, Sharma R, Devi JR, Khanna N. Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition. 2003;19:503–9.
Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand. 2002;81(7):603–11.
Acknowledgments
The authors wish to express their acknowledgement to the Principal of GMCH, Professor and HOD of Endocrinology, Medicine and Cardiology Department of GMCH and the Department of Biochemistry of GMC Guwahati, Assam.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Goyal, S., Baruah, M., Devi, R. et al. Study on Relation of Metabolic Syndrome with Menopause. Ind J Clin Biochem 28, 55–60 (2013). https://doi.org/10.1007/s12291-012-0243-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0243-6